Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

Conditions

• Tuberculosis
• Pre-XDR-TB
• Extensively Drug-Resistant Tuberculosis
• Multi Drug Resistant Tuberculosis
• Rifampicin Resistant Tuberculosis

Interventions

• DRUG: Bedaquiline Oral Tablet
• DRUG: Linezolid Oral Tablet
• DRUG: Delamanid in Oral Dosage Form
• DRUG: Clofazimine Oral Product
• DRUG: Levofloxacin Oral Tablet
• DRUG: Isoniazid Oral Product
• DRUG: Ethambutol Oral Product
• DRUG: Pyrazinamide Oral Product
• DRUG: Linezolid Oral Tablet
• DRUG: Clofazimine Oral Product
• DRUG: Levofloxacin Oral Tablet

Sponsor

Wits Health Consortium (Pty) Ltd

Collaborators

• [object Object]
• [object Object]
• [object Object]